- Home
- ONL vs KRRO Comparison
ONL vs KRRO Comparison
Compare ONL & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONL | KRRO |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.2M | 101.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ONL | KRRO |
|---|---|---|
| Price | $2.55 | $11.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | $3.00 | ★ $54.60 |
| AVG Volume (30 Days) | ★ 322.9K | 286.0K |
| Earning Date | 03-05-2026 | 03-17-2026 |
| Dividend Yield | ★ 3.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $149,775,000.00 | $7,371,000.00 |
| Revenue This Year | N/A | $145.97 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.46 | $5.20 |
| 52 Week High | $4.25 | $55.89 |
Technical Indicators
Market Signals| Indicator | ONL | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 64.28 | 50.84 |
| Support Level | $2.15 | $11.33 |
| Resistance Level | $2.67 | $12.81 |
| Average True Range (ATR) | 0.14 | 1.13 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 80.99 | 29.07 |
Price Performance
Historical ComparisonAbout ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.